1 Introduction to Research & Analysis Reports 1.1 Chronic Plaque Psoriasis Therapeutics Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Chronic Plaque Psoriasis Therapeutics Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Chronic Plaque Psoriasis Therapeutics Overall Market Size 2.1 United States Chronic Plaque Psoriasis Therapeutics Market Size: 2021 VS 2027 2.2 United States Chronic Plaque Psoriasis Therapeutics Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Chronic Plaque Psoriasis Therapeutics Players in United States Market 3.2 Top United States Chronic Plaque Psoriasis Therapeutics Companies Ranked by Revenue 3.3 United States Chronic Plaque Psoriasis Therapeutics Revenue by Companies 3.4 Top 3 and Top 5 Chronic Plaque Psoriasis Therapeutics Companies in United States Market, by Revenue in 2020 3.5 Companies Chronic Plaque Psoriasis Therapeutics Product Type 3.6 Tier 1, Tier 2 and Tier 3 Chronic Plaque Psoriasis Therapeutics Players in United States Market 3.6.1 List of Tier 1 Chronic Plaque Psoriasis Therapeutics Companies in United States 3.6.2 List of Tier 2 and Tier 3 Chronic Plaque Psoriasis Therapeutics Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Chronic Plaque Psoriasis Therapeutics Market Size Markets, 2021 & 2027 4.1.2 Clinical 4.1.3 Non-Clinical 4.1.4 Inactive 4.2 By Type - United States Chronic Plaque Psoriasis Therapeutics Revenue & Forecasts 4.2.1 By Type - United States Chronic Plaque Psoriasis Therapeutics Revenue, 2016-2021 4.2.2 By Type - United States Chronic Plaque Psoriasis Therapeutics Revenue, 2022-2027 4.2.3 By Type - United States Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Chronic Plaque Psoriasis Therapeutics Market Size, 2021 & 2027 5.1.2 Hospitals 5.1.3 Ambulatory Surgical Centers 5.1.4 Others 5.2 By Application - United States Chronic Plaque Psoriasis Therapeutics Revenue & Forecasts 5.2.1 By Application - United States Chronic Plaque Psoriasis Therapeutics Revenue, 2016-2021 5.2.2 By Application - United States Chronic Plaque Psoriasis Therapeutics Revenue, 2022-2027 5.2.3 By Application - United States Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2016-2027 6 Chronic Plaque Psoriasis Therapeutics Companies Profiles 6.1 Abbvie 6.1.1 Abbvie Company Details 6.1.2 Abbvie Business Overview 6.1.3 Abbvie Chronic Plaque Psoriasis Therapeutics Introduction 6.1.4 Abbvie Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.1.5 Abbvie Recent Developments 6.2 Novartis International 6.2.1 Novartis International Company Details 6.2.2 Novartis International Business Overview 6.2.3 Novartis International Chronic Plaque Psoriasis Therapeutics Introduction 6.2.4 Novartis International Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.2.5 Novartis International Recent Developments 6.3 Pfizer 6.3.1 Pfizer Company Details 6.3.2 Pfizer Business Overview 6.3.3 Pfizer Chronic Plaque Psoriasis Therapeutics Introduction 6.3.4 Pfizer Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.3.5 Pfizer Recent Developments 6.4 Merck 6.4.1 Merck Company Details 6.4.2 Merck Business Overview 6.4.3 Merck Chronic Plaque Psoriasis Therapeutics Introduction 6.4.4 Merck Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.4.5 Merck Recent Developments 6.5 Astelllas Pharma 6.5.1 Astelllas Pharma Company Details 6.5.2 Astelllas Pharma Business Overview 6.5.3 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Introduction 6.5.4 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.5.5 Astelllas Pharma Recent Developments 6.6 GlaxoSmithKline 6.6.1 GlaxoSmithKline Company Details 6.6.2 GlaxoSmithKline Business Overview 6.6.3 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Introduction 6.6.4 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) 6.6.5 GlaxoSmithKline Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Chronic Plaque Psoriasis Therapeutics Market Opportunities & Trends in United States Market Table 2. Chronic Plaque Psoriasis Therapeutics Market Drivers in United States Market Table 3. Chronic Plaque Psoriasis Therapeutics Market Restraints in United States Market Table 4. Key Players of Chronic Plaque Psoriasis Therapeutics in United States Market Table 5. Top Chronic Plaque Psoriasis Therapeutics Players in United States Market, Ranking by Revenue (2019) Table 6. United States Chronic Plaque Psoriasis Therapeutics Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Chronic Plaque Psoriasis Therapeutics Revenue Share by Companies, 2016-2021 Table 8. Companies Chronic Plaque Psoriasis Therapeutics Product Type Table 9. List of Tier 1 Chronic Plaque Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Chronic Plaque Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – United States Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), 2022-2027 Table 14. By Application – United States Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), 2022-2027 Table 17. Abbvie Company Details Table 18. Abbvie Business Overview Table 19. Abbvie Chronic Plaque Psoriasis Therapeutics Product Table 20. Abbvie Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Abbvie Recent Developments Table 22. Novartis International Company Details Table 23. Novartis International Business Overview Table 24. Novartis International Chronic Plaque Psoriasis Therapeutics Product Table 25. Novartis International Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Novartis International Recent Developments Table 27. Pfizer Company Details Table 28. Pfizer Business Overview Table 29. Pfizer Chronic Plaque Psoriasis Therapeutics Product Table 30. Pfizer Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Pfizer Recent Developments Table 32. Merck Company Details Table 33. Merck Business Overview Table 34. Merck Chronic Plaque Psoriasis Therapeutics Product Table 35. Merck Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Merck Recent Developments Table 37. Astelllas Pharma Company Details Table 38. Astelllas Pharma Business Overview Table 39. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Product Table 40. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Astelllas Pharma Recent Developments Table 42. GlaxoSmithKline Company Details Table 43. GlaxoSmithKline Business Overview Table 44. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Product Table 45. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Revenue in United States Market (2016-2021) & (US$ Million) Table 46. GlaxoSmithKline Recent Developments List of Figures Figure 1. Chronic Plaque Psoriasis Therapeutics Segment by Type Figure 2. Chronic Plaque Psoriasis Therapeutics Segment by Application Figure 3. United States Chronic Plaque Psoriasis Therapeutics Market Overview: 2020 Figure 4. United States Chronic Plaque Psoriasis Therapeutics Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Chronic Plaque Psoriasis Therapeutics Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue in 2020 Figure 7. By Type - United States Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2016-2027 Figure 8. By Application - United States Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2016-2027 Figure 9. Abbvie Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Novartis International Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Pfizer Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Merck Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Abbvie Novartis International Pfizer Merck Astelllas Pharma GlaxoSmithKline